A prostate cancer-specific Balanced Scorecard is developed encompassing diverse perspectives for prostate cancer centers and ensures manageable indicators, which enables value creation in the sense of Porter's "full cycle of care" through the systematic capture of economic, personnel-related, and medical key figures.
Abstract
Background
Prostate cancer (PC) is the most common cancer in men in Germany, accounting for 29% of all malignancies. Since it cannot be prevented, improved diagnostics and therapy are required. Within the framework of so-called value-based healthcare, the Balanced Scorecard (BSC) has been established as a measurement instrument for achieving such improvements.
Objective
The aim of the present study was to develop a BSC for the treatment of localized prostate cancer.
Materials And Methods
BSCs assess the performance of healthcare organizations across multiple dimensions: financial, patient and referrer, process, and learning and development perspectives. The goal was to identify key performance indicators (KPIs) for each perspective. In addition, a novel disease and outcomes perspective was established specifically for prostate cancer. A systematic literature review conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines across multiple databases identified relevant KPIs.
Results
A PC-specific BSC was developed encompassing KPIs for the four classical perspectives as well as a novel disease and outcomes perspective, incorporating parameters from the certification process of the German Cancer Society (GCS; Deutsche Krebsgesellschaft) and the International Consortium for Health Outcome Measurement (ICHOM). Among other elements, the process perspective includes KPIs relating to the training of resident physicians, and the learning and development perspective contains metrics for the structured training of radical prostatectomy.
Conclusion
The BSC encompasses diverse perspectives for prostate cancer centers and ensures manageable indicators. It enables value creation in the sense of Porter's "full cycle of care" through the systematic capture of economic, personnel-related, and medical key figures. In particular, it contains KPIs for the structured training of surgeons and metrics of the GCS that have been shown to demonstrably improve patient outcomes.
This robust survey demonstrates that the current quality metrics of VBP models used in cancer care and the priorities of financially underserved patients living with cancer in the US are misaligned.
Kimberly D. Brunisholz, Rebekah S. M. Angove, K. Gallagher et al.· JCO Oncology Practice· 0 citations
565
Background:
Delivery of high-quality breast cancer care is a universal mandate in many global healthcare systems. The WHO Global Breast Cancer Initiative (GBCI) highlights timeliness of diagnosis and treatment initiation as a major component of improving patient outcomes and decreasing global disparity for...
D. Chan, Amilya Ladak, N. Levasseur et al.· JCO Oncology Practice· 0 citations
Task-shared, multidisciplinary pathways of value-based approaches appear to be a promising approach to breast cancer care in Morocco and other LMIC countries, however further local implementation research and cost-effectiveness studies are required.
M. Azaroual, Mohd Faizan Siddiqui· JCO Oncology Practice· 0 citations
758
Background:
Breast cancer risk prediction scores, such as the Gail Model, are commonly implemented in the Electronic Health Record (EHR) to guide clinical decision-making regarding breast cancer screening and chemoprevention. Yet, their implementation is inconsistent or limited to specific time periods or p...
Michelle Pistner Nixon, D. Hassen, Alicia M. Johns et al.· JCO Oncology Practice· 0 citations
OBJECTIVE
Patient-reported outcomes (PROs) for individual patients with colorectal cancer (CRC) can be interpreted by using PRO scores with thresholds for clinical importance (TCIs). This study established TCIs for the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Colorectal C...
K. D. de Ligt, M. Pilz, Maike Thumfart et al.· Journal of Clinical Epidemio...· 0 citations
717
Background:
Despite treatment advances in small cell lung cancer (SCLC), significant variability persists in care delivery across institutions. Differences in diagnostic approaches, treatment coordination, and supportive care can impact patient outcomes. To address these gaps, the Association of Cancer Care...
Bianca Alvarez, Amir Sajadian, G. Cumbo-Nacheli et al.· JCO Oncology Practice· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.